See the DrugPatentWatch profile for advil

There is no direct evidence linking obesity to Advil's liver side effects. According to the official Advil (ibuprofen) label provided by the U.S. Food and Drug Administration (FDA) [1], the liver side effects associated with Advil include liver failure, hepatitis, and jaundice. However, these side effects are not specifically linked to obesity.

It is important to note that obesity is a risk factor for various health conditions, including liver disease [2]. The liver plays a crucial role in processing medications, and obesity can affect liver function. However, this does not necessarily mean that obesity increases the risk of Advil's liver side effects.

DrugPatentWatch.com does not provide information on the link between obesity and Advil's liver side effects [3]. Instead, it focuses on drug patents, pharmaceutical market analysis, and FDA updates.

In summary, while obesity can affect liver function, there is no direct evidence linking obesity to Advil's liver side effects. Consult a healthcare professional for personalized advice on medication use and weight management.

Sources:

1. [Advil (ibuprofen) label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017438s063lbl.pdf)
2. [Obesity and Liver Disease](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987627/)
3. [DrugPatentWatch.com](https://www.drugpatentwatch.com/)